A Rare Case of Tirzepatide-Induced Hepatitis: Causality Assessment With the RUCAM Criteria
Tirzepatide is an effective medication that targets both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, resulting in weight loss, improved glycemic control, and better cardiovascular and renal outcomes. Despite that, tirzepatide may have unfavorable consequences....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2025-01-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|